HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bill Takes Small Step Toward More Nanotech Research, Commercialization

This article was originally published in The Rose Sheet

Executive Summary

Congress is recognizing the need for direction in nanotechnology research, but researchers and consumer safety advocates say more is needed to spur further nanotech commercialization and adequately protect the public from potential dangers
Advertisement

Related Content

House Kicks Off New Year With Bill To Sharpen Federal Nanotech Plan
House Kicks Off New Year With Bill To Sharpen Federal Nanotech Plan
U.S. Spending On Nanotech Research Questioned With Goods Flooding Market
U.S. Spending On Nanotech Research Questioned With Goods Flooding Market
FDA Challenge In Regulating Esoteric Nanotechnology Discussed At FDLI
Advertisement
UsernamePublicRestriction

Register

RS015494

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel